Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
Interventions
- BIOLOGICAL: filgrastim
- DRUG: melphalan
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
Northwestern University
Collaborators